Development Level
Tbio | 88 | 10,625 | |
Tchem | 21 | 1,890 | |
Tdark | 4 | 7,003 | |
Tclin | 1 | 602 |
IMPC Term
preweaning lethality, complete... | 11 | 633 | |
decreased body weight | 3 | 174 | |
decreased bone mineral content | 3 | 157 | |
decreased total body fat amoun... | 3 | 186 | |
abnormal embryo size | 2 | 112 | |
abnormal heart left ventricle ... | 2 | 20 | |
abnormal kidney morphology | 2 | 30 | |
abnormal lens morphology | 2 | 73 | |
decreased lean body mass | 2 | 195 | |
embryonic lethality prior to o... | 2 | 148 | |
embryonic lethality prior to t... | 2 | 187 | |
increased bone mineral content | 2 | 92 | |
increased lean body mass | 2 | 107 | |
prenatal lethality prior to he... | 2 | 64 | |
preweaning lethality, incomple... | 2 | 260 | |
abnormal QRS complex | 1 | 25 | |
abnormal body wall morphology | 1 | 7 | |
abnormal bone mineralization | 1 | 55 | |
abnormal coping response | 1 | 12 | |
abnormal eye morphology | 1 | 38 | |
abnormal eye size | 1 | 11 | |
abnormal glucose homeostasis | 1 | 5 | |
abnormal retina morphology | 1 | 100 | |
abnormal retinal inner nuclear... | 1 | 5 | |
abnormal skin appearance | 1 | 8 | |
abnormal tail movements | 1 | 12 | |
abnormal vitreous body morphol... | 1 | 7 | |
abnormal vocalization | 1 | 21 | |
anophthalmia | 1 | 20 | |
craniofacial phenotype | 1 | 9 | |
decreased IgM level | 1 | 1 | |
decreased NK T cell number | 1 | 28 | |
decreased blood urea nitrogen ... | 1 | 31 | |
decreased body length | 1 | 108 | |
decreased bone mineral density | 1 | 126 | |
decreased circulating HDL chol... | 1 | 77 | |
decreased circulating calcium ... | 1 | 33 | |
decreased circulating serum al... | 1 | 79 | |
decreased spleen weight | 1 | 13 | |
herniated abdominal wall | 1 | 4 | |
hydrops fetalis | 1 | 22 | |
increased NK T cell number | 1 | 11 | |
increased body weight | 1 | 42 | |
increased circulating alkaline... | 1 | 119 | |
increased circulating bilirubi... | 1 | 16 | |
increased circulating chloride... | 1 | 43 | |
increased circulating choleste... | 1 | 53 | |
increased circulating free fat... | 1 | 17 | |
increased circulating fructosa... | 1 | 11 | |
increased circulating serum al... | 1 | 25 | |
increased circulating sodium l... | 1 | 71 | |
increased exploration in new e... | 1 | 56 | |
increased grip strength | 1 | 83 | |
increased heart rate variabili... | 1 | 4 | |
increased marginal zone B cell... | 1 | 3 | |
increased or absent threshold ... | 1 | 128 | |
increased rib number | 1 | 41 | |
microphthalmia | 1 | 15 | |
pale yolk sac | 1 | 12 | |
small adrenal glands | 1 | 15 | |
thrombocytopenia | 1 | 46 |
Disease
Tissue
Blood and immune system | 114 | 17,995 | |
Cardiovascular System | 114 | 17,958 | |
Digestive Tract | 114 | 18,473 | |
Endocrine System | 114 | 18,512 | |
Female tissues | 114 | 18,647 | |
Liver and Pancreas | 114 | 18,136 | |
Male tissues | 114 | 17,969 | |
Nervous System | 114 | 18,561 | |
Respiratory system | 114 | 17,484 | |
Urinary Tract | 114 | 18,444 | |
Skin and soft tissues | 112 | 18,115 |
KEGG Pathway
Carbon metabolism | 114 | 114 | |
Metabolic pathways | 1,254 | 1,254 | |
Olfactory transduction | 412 | 412 | |
Pathways in cancer | 402 | 402 | |
HTLV-I infection | 339 | 339 | |
PI3K-Akt signaling pathway | 338 | 338 | |
Endocytosis | 326 | 326 | |
Epstein-Barr virus infection | 279 | 279 | |
Neuroactive ligand-receptor in... | 276 | 276 | |
Cytokine-cytokine receptor int... | 262 | 262 | |
Herpes simplex infection | 262 | 262 | |
MAPK signaling pathway | 255 | 255 | |
Viral carcinogenesis | 253 | 253 | |
Phagosome | 231 | 231 | |
Cell adhesion molecules (CAMs) | 225 | 225 | |
Ras signaling pathway | 225 | 225 | |
Rap1 signaling pathway | 213 | 213 | |
Regulation of actin cytoskelet... | 213 | 213 | |
Proteoglycans in cancer | 202 | 202 | |
cAMP signaling pathway | 201 | 201 | |
Focal adhesion | 200 | 200 | |
Natural killer cell mediated c... | 199 | 199 | |
Huntington's disease | 194 | 194 | |
Tuberculosis | 187 | 187 | |
Influenza A | 184 | 184 | |
Chemokine signaling pathway | 182 | 182 | |
Calcium signaling pathway | 181 | 181 | |
Axon guidance | 176 | 176 | |
Purine metabolism | 171 | 171 | |
Alzheimer's disease | 169 | 169 | |
Tight junction | 169 | 169 | |
NOD-like receptor signaling pa... | 168 | 168 | |
Protein processing in endoplas... | 165 | 165 | |
Transcriptional misregulation ... | 165 | 165 | |
cGMP-PKG signaling pathway | 165 | 165 | |
RNA transport | 164 | 164 | |
Oxytocin signaling pathway | 158 | 158 | |
Jak-STAT signaling pathway | 157 | 157 | |
Antigen processing and present... | 156 | 156 | |
Hippo signaling pathway | 154 | 154 | |
mTOR signaling pathway | 153 | 153 | |
Non-alcoholic fatty liver dise... | 151 | 151 | |
Adrenergic signaling in cardio... | 150 | 150 | |
MicroRNAs in cancer | 150 | 150 | |
Breast cancer | 146 | 146 | |
Alcoholism | 145 | 145 | |
Hepatitis B | 145 | 145 | |
Phospholipase D signaling path... | 145 | 145 | |
Parkinson's disease | 142 | 142 | |
Wnt signaling pathway | 142 | 142 | |
Signaling pathways regulating ... | 141 | 141 | |
Apoptosis | 140 | 140 | |
Insulin signaling pathway | 138 | 138 | |
Ubiquitin mediated proteolysis | 137 | 137 | |
Viral myocarditis | 137 | 137 | |
Measles | 135 | 135 | |
Ribosome | 134 | 134 | |
Oxidative phosphorylation | 133 | 133 | |
FoxO signaling pathway | 132 | 132 | |
Hepatitis C | 132 | 132 | |
Spliceosome | 132 | 132 | |
Dopaminergic synapse | 131 | 131 | |
Osteoclast differentiation | 131 | 131 | |
Autoimmune thyroid disease | 130 | 130 | |
Toxoplasmosis | 130 | 130 | |
Cell cycle | 125 | 125 | |
Platelet activation | 124 | 124 | |
AMPK signaling pathway | 123 | 123 | |
Lysosome | 123 | 123 | |
Type I diabetes mellitus | 122 | 122 | |
Vascular smooth muscle contrac... | 121 | 121 | |
Graft-versus-host disease | 120 | 120 | |
Sphingolipid signaling pathway | 120 | 120 | |
Neurotrophin signaling pathway | 119 | 119 | |
Oocyte meiosis | 119 | 119 | |
Th17 cell differentiation | 119 | 119 | |
Thyroid hormone signaling path... | 118 | 118 | |
Allograft rejection | 116 | 116 | |
Glutamatergic synapse | 116 | 116 | |
Leukocyte transendothelial mig... | 116 | 116 | |
Serotonergic synapse | 114 | 114 | |
Cholinergic synapse | 110 | 110 | |
TNF signaling pathway | 110 | 110 | |
Insulin resistance | 109 | 109 | |
Hematopoietic cell lineage | 108 | 108 | |
Systemic lupus erythematosus | 108 | 108 | |
Chagas disease (American trypa... | 106 | 106 | |
T cell receptor signaling path... | 104 | 104 | |
Th1 and Th2 cell differentiati... | 104 | 104 | |
Glucagon signaling pathway | 103 | 103 | |
HIF-1 signaling pathway | 103 | 103 | |
Toll-like receptor signaling p... | 103 | 103 | |
Melanogenesis | 102 | 102 | |
Pyrimidine metabolism | 102 | 102 | |
AGE-RAGE signaling pathway in ... | 101 | 101 | |
Endocrine resistance | 101 | 101 | |
Estrogen signaling pathway | 101 | 101 | |
Retrograde endocannabinoid sig... | 101 | 101 | |
Amoebiasis | 100 | 100 | |
Rheumatoid arthritis | 100 | 100 |
This is where graphics are reside..